Andrologic examinations in the antimetabolite therapy of psoriasis
Günther, E.
Dermatologische Monatschrift 156(5): 498-502
1970
ISSN/ISBN: 0011-9083 PMID: 5509154 Document Number: 22602
Document emailed within 1 workday
Related Documents
Snir, M.; Lusky, M.; Shalev, B.; Gaton, D.; Weinberger, D. 2000: Mitomycin C and 5-fluorouracil antimetabolite therapy for pediatric glaucoma filtration surgery Ophthalmic Surgery and Lasers 31(1): 31-37Schramm, P. 1994: Andrologic therapy--criteria for assessing treatment success Fortschritte der Medizin 112(14): 197-198
Zlatkov, N.B. 1970: Genaelogic and cytogenetic examinations in psoriasis Dermatologische Monatschrift 156(5): 470-478
Wong, J.W.; Kamangar, F.; Nguyen, T.V.; Koo, J.Y.M. 2012: Excimer laser therapy for hairline psoriasis: a useful addition to the scalp psoriasis treatment algorithm Skin Therapy Letter 17(5): 6-9
Ekiel, I.; Shugar, D. 1979: Solution conformations of the antimetabolite 9-beta-D-xylofuranosyladenine and its 8-bromo analogue Acta Biochimica Polonica 26(4): 435-444
Austoni, E.; Tonazzi, G.L.; Cazzaniga, A.; Ardizzone, M.V.; Macola, G.G.; Gatti, G.; Fenice, O.; Goumas, Y.K.; Dell'Aglio, F. 1998: Andrologic surgery Archivio Italiano di Urologia Andrologia: Organo Ufficiale di Societa Italiana di Ecografia Urologica e Nefrologica 70(3 Suppl): 67-68
Swaffar, D.S.; Ang, C.Y.; Desai, P.B.; Rosenthal, G.A. 1994: Inhibition of the growth of human pancreatic cancer cells by the arginine antimetabolite L-canavanine Cancer Research 54(23): 6045-6048
Ray, M.S.; Muggia, F.M.; Leichman, C.G.; Grunberg, S.M.; Nelson, R.L.; Dyke, R.W.; Moran, R.G. 1993: Phase I study of (6R)-5,10-dideazatetrahydrofolate: a folate antimetabolite inhibitory to de novo purine synthesis Journal of the National Cancer Institute 85(14): 1154-1159
Schramm, P.; Hommel, G.; Schill, W.B. 1984: Pentoxifylline--an andrologic drug? Zeitschrift für Hautkrankheiten 59(20): 1379-1382
Schütte, B. 1990: Andrologic problems in adolescence Zeitschrift für Hautkrankheiten 65(4): 324; 327-333
Sauter, C. 1988: Follow up examinations in cytostatic therapy Schweizerische Medizinische Wochenschrift 118(11): 398-400
Ellis, C.N.; Fradin, M.S.; Hamilton, T.A.; Voorhees, J.J. 1995: Duration of remission during maintenance cyclosporine therapy for psoriasis. Relationship to maintenance dose and degree of improvement during initial therapy Archives of Dermatology 131(7): 791-795
Ormea, F. 1976: Therapy of psoriasis Minerva Medica 67(55): 3565-3572
Olusanya, B.A.; Ogun, O.A.; Bekibele, C.O.; Ashaye, A.O.; Baiyeroju, A.M.; Fasina, O.; Ogundipe, A.O.; Ibrahim, A.O. 2014: Risk factors for pterygium recurrence after surgical excision with combined conjunctival autograft (CAG) and intraoperative antimetabolite use African Journal of Medicine and Medical Sciences 43(1): 35-40
Sas, M.; Apró, G.; Falkay, G. 1977: LH-RH loading tests in andrologic patients with hypogonadism Orvosi Hetilap 118(32): 1887-1890
Block, J.B.; Chlebowski, R.T.; Dietrich, M.F.; Isacoff, W.H. 1984: Abnormal deoxyuridine suppression as a rapid predictor for antimetabolite chemosensitivity: correlation with in vitro tests of growth inhibition Cancer Treatment Reports 68(4): 631-636
Neumann, M.; Hiller, H. 1970: Tonographic examinations during local injection therapy with dexamethasone Klinische Monatsblatter für Augenheilkunde 157(3): 334-342
Fusco, R.J.; Jordan, P.A.; Kelly, A.; Samuel, M. 1980: PUVA therapy for psoriasis PhysioTherapy 66(2): 39-40
Panizzon, R. 1995: Psoriasis: diagnosis and therapy Praxis 84(22): 649-653
Jørsing, K. 1992: Psoriasis and anticoagulant therapy Ugeskrift for Laeger 154(35): 2373-2374